Work

Mepolizumab is not inferior to omalizumab, improving asthma control in severe allergic and eosinophilic asthma, a randomised, blinded, non-inferiority trial.

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.pa4747

Authors: Peter Wark, Lorena Rodriques Sabino, Erin Nolan, Peter Gibson, Vanessa Mcdonald, John Upham, Elaine Yap, Elizabeth Holliday

Institutions: Monash University, University of Newcastle Australia, The University of Queensland, Middlemore Hospital

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404096919

Cites:

Cited by: 1

Related to: 10